#nordisk — Public Fediverse posts

https://www.europesays.com/dk/83478/ Novo Nordisk Faces First Generic Challenge in Canada as Wegovy Oral Pill Dominates US Market #Canada #challenge #faces #First #Generic #Nordisk #novo #NovoNordisk #Oral #pill #Wegovy

https://www.europesays.com/dk/83315/ Novo Nordisk’s Oral Wegovy Wins Patient Preference as Long-Term Efficacy Data Strengthens Case #data #Efficacy #LongTerm #Nordisk’s #novo #NovoNordisk #Oral #patient #Preference #Wegovy #wins

https://www.europesays.com/dk/83149/ Novo Nordisk Streamlines Operations as Oral Wegovy Data Reinforce Obesity Strategy #data #Nordisk #novo #NovoNordisk #Obesity #operations #Oral #Reinforce #strategy #Streamlines #Wegovy

https://www.europesays.com/dk/?p=82966 Novo Nordisk Finds Footing as Oral Wegovy Data Bolsters Recovery from Steep Sell-Off #Bolsters #data #Finds #Footing #Nordisk #novo #NovoNordisk #Oral #Recovery #Steep #Wegovy

https://www.europesays.com/dk/82884/ Novo Nordisk Bets on Oral Pill and CagriSema to Reclaim Obesity Leadership After 60% Sell-Off #after #Bets #cagrisema #leadership #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Reclaim

https://www.europesays.com/dk/82796/ Novo Nordisk Scraps Rare-Disease Factory, Bets on Oral Obesity Pill and CagriSema to Revive Growth #Bets #cagrisema #factory #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #RareDisease #Scraps

https://www.europesays.com/dk/82719/ Novo Nordisk Redoubles Metabolic Efforts as Parkinson Divestiture and Analyst Upgrade Align #Align #analyst #Divestiture #efforts #Metabolic #Nordisk #novo #NovoNordisk #Parkinson #Redoubles #Upgrade

https://www.europesays.com/dk/82692/ Novo Nordisk Sheds Stray Assets to Double Down on Obesity Pipeline as Oral Wegovy Gains Traction #assets #double #down #Nordisk #novo #NovoNordisk #Obesity #Oral #pipeline #Sheds #Stray

https://www.europesays.com/dk/?p=82557 Novo Nordisk Touts Muscle-Sparing Weight Loss Data as CagriSema Decision Looms #cagrisema #data #Decision #Looms #Loss #MuscleSparing #Nordisk #novo #NovoNordisk #Touts #Weight

https://www.europesays.com/dk/82519/ Novo Nordisk Combines Direct-to-Patient Service with Analyst Optimism in Obesity Fight #analyst #Combines #DirectToPatient #Fight #Hedgeye #Nordisk #novo #NovoNordisk #Obesity #Optimism #Service

https://www.europesays.com/dk/82162/ Novo Nordisk’s Strategic Pivot Gains Traction as Clinical Data and Analyst Forecast Align #analyst #Clinical #data #forecast #Gains #Nordisk’s #novo #NovoNordisk #Pivot #Strategic #Traction

https://www.europesays.com/dk/82153/ Novo Nordisk Streamlines Metabolism Focus as Menopause Data and Analyst Upgrade Signal Turnaround #analyst #data #Focus #menopause #Metabolism #Nordisk #novo #NovoNordisk #signal #Streamlines #Upgrade

https://www.europesays.com/dk/82071/ Novo Nordisk’s Comeback Narrative Gains Steam from Analyst Upgrade, Clinical Data and Canadian Acc #analyst #Clinical #comeback #data #Gains #Narrative #Nordisk’s #novo #NovoNordisk #steam #Upgrade

https://www.europesays.com/dk/81882/ Novo Nordisk Restructures Domestic Footprint as Oral Wegovy Pill Outpaces Rival #domestic #footprint #Nordisk #novo #NovoNordisk #Oral #Outpaces #pill #Restructures #Rival #Wegovy

https://www.europesays.com/dk/81829/ Novo Nordisk Tightens Operations as Oral Wegovy Pill Sales Double Expectations #double #Expectations #Nordisk #novo #NovoNordisk #operations #Oral #pill #sales #Tightens #Wegovy

https://www.europesays.com/dk/81586/ Novo Nordisk’s Oral Wegovy Pill Defies Expectations as Data Blitz Reshapes Obesity Market Battle #Blitz #data #defies #Expectations #Nordisk’s #novo #NovoNordisk #Oral #pill #Reshapes #Wegovy

https://www.europesays.com/dk/81571/ Novo Nordisk Balances Canadian Price Pressure With Sickle Cell Advance and Oral Pill Triumph #Advance #Balances #Canadian #cell #Nordisk #novo #NovoNordisk #pressure #price #Sickle #with

https://www.europesays.com/dk/81487/ Menopause Heart Data, Oral Pill Revenue Double, and a Parkinso #data #Flexes #heart #menopause #Metabolic #Muscle #Nordisk #novo #NovoNordisk #Oral #pill

https://www.europesays.com/dk/81467/ Novo Nordisk’s Wegovy Pill Boosts Mobility in 8 of 10 Patients as Quarterly Sales Surge Past Expec #Boosts #mobility #Nordisk’s #novo #NovoNordisk #patients #pill #Quarterly #sales #surge #Wegovy

https://www.europesays.com/dk/81273/ Novo Nordisk’s Oral Wegovy Sales Surprise Caps Strong Data Showing at Istanbul Obesity Congress #Caps #data #Nordisk’s #novo #NovoNordisk #Oral #sales #Showing #strong #Surprise #Wegovy

https://www.europesays.com/dk/81253/ Fat-Loss Data Impress as Oral Wegovy Sales Double Expectations #data #double #FatLoss #Impress #Nordisk #novo #NovoNordisk #Oral #scores #Wegovy #win

https://www.europesays.com/dk/80679/ Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons #A/S #and #associated #board #by #executives #in #Members #Nordisk #novo #NovoNordisk #persons #shares #Trading

https://www.europesays.com/dk/80473/ Novo Nordisk A/S: Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity #A/S #Across #All #and #at #congress #data #delivered #european #heart #in #Loss #menopause #migraine #new #Nordisk #novo #NovoNordisk #Obesity #on #plus #protection #shown #stages #substantial #the #Wegovy #Weight #women

https://www.europesays.com/dk/80292/ Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #28% #A/S #according #analyses #at #congress #demonstrates #dose #early #european #higher #in #Loss #nearly #new #Nordisk #novo #NovoNordisk #Obesity #on #presented #responders #the #to #Wegovy #Weight

https://www.europesays.com/dk/80242/ Novo Nordisk Gears Up for ORION Showdown as Obesity Congress Highlights Pill and Pipeline Gains #congress #Gears #highlights #Nordisk #novo #NovoNordisk #Obesity #ORION #pill #pipeline #Showdown

https://www.europesays.com/dk/80192/ Novo Nordisk’s Oral Wegovy Smashes Expectations, but Margin Pressure and Rival Threats Cloud the O #Cloud #Expectations #Nordisk’s #novo #NovoNordisk #Oral #pressure #Rival #Smashes #threats #Wegovy

https://www.europesays.com/dk/79324/ Novo Nordisk’s Oral Wegovy Defies Gravity as FDA Poised to Curb Compounders #Compounders #Curb #defies #FDA #Gravity #Nordisk’s #novo #NovoNordisk #Oral #Poised #Wegovy

https://www.europesays.com/dk/77834/ Novo Nordisk’s One-Time Windfall Masks a Deeper Squeeze as Pipeline Bets Take Shape #Bets #Deeper #Masks #Nordisk’s #novo #NovoNordisk #OneTime #pipeline #Squeeze #take #Windfall

https://www.europesays.com/dk/76881/ Novo Nordisk’s Profit Surge Masks the Real Story: A Pipeline Pivot Underway #Masks #Nordisk’s #novo #NovoNordisk #pipeline #Pivot #profit #Real #story #surge #Underway

https://www.europesays.com/dk/76600/ Novo Nordisk’s Pill Push Eases the Pain, but the Generics Are Already Circling #Already #are #Circling #Eases #generics #Nordisk’s #novo #NovoNordisk #pain #pill #Push

https://www.europesays.com/dk/76423/ Novo Nordisk’s Wegovy Pill Rewrites the Launch Playbook, but a One-Time Windfall Skews the Numbers #Launch #Nordisk’s #novo #NovoNordisk #OneTime #pill #Playbook #Rewrites #Skews #Wegovy #Windfall

https://www.europesays.com/dk/75582/ Novo Nordisk’s Pill Pivot Faces Its First Big Test on Wednesday #BIG #faces #First #Its #Nordisk’s #novo #NovoNordisk #pill #Pivot #test #Wednesday

https://www.europesays.com/dk/75463/ Can a Pill and a Buyback Turn the Tide? #billion #Buyback #Can #Nordisk #Nordisk’s #novo #NovoNordisk #pill #Tide #Turn #Wipeout

https://www.europesays.com/dk/75156/ Novo Nordisk’s Oral GLP-1 Offensive Meets a Wall Street Reality Check #check #GLP1 #Meets #Nordisk’s #novo #NovoNordisk #Offensive #Oral #reality #street #wall

https://www.europesays.com/dk/74353/ Novo Nordisk Puts Oral Ozempic on Pharmacy Shelves Just Days Before a Make-or-Break Earnings Report #Before #days #just #Nordisk #novo #NovoNordisk #Oral #ozempic #pharmacy #Puts #Shelves

https://www.europesays.com/dk/74111/ Oral Ozempic Hits Pharmacies as Earnings Test Investor Patience #earnings #HighStakes #hits #Nordisk’s #novo #NovoNordisk #Oral #ozempic #pharmacies #test #week

https://www.europesays.com/dk/74107/ Generics, Pipeline Wins, and a Pivotal Earnings Report #Crossroads #Crucial #earnings #faces #generics #Nordisk #novo #NovoNordisk #pipeline #Pivotal #wins

https://www.europesays.com/dk/73881/ Novo Nordisk’s Oral Ozempic Arrives as GLP-1 Data Opens New Frontier #Arrives #data #Frontier #GLP1 #new #Nordisk’s #novo #NovoNordisk #Opens #Oral #ozempic

https://www.europesays.com/no/228281/ Linda var død i ti minutter #BreakingNews #BreakingNews #død #FeaturedNews #FeaturedNews #Headlines #helse #Hjertestans #LatestNews #LatestNews #LivreddendeFørstehjelp #News #NO #nordisk #Norge #Norway #Nyheter #Overskrifter #pluss #tema #TopStories #TopStories #Verden #World #WorldNews #WorldNews

https://www.europesays.com/dk/73654/ Oral Ozempic Arrives as Q1 Results Loom #Arrives #Loom #Nordisk #Nordisk’s #novo #NovoNordisk #Oral #ozempic #Pivotal #results #week

https://www.europesays.com/dk/73591/ FDA Curbs Copycats as Oral Ozempic Hits 70,000 Pharmacies #Copycats #Curbs #FDA #hits #Nordisk’s #novo #NovoNordisk #OneTwo #Oral #ozempic #Punch

https://www.europesays.com/dk/73332/ Novo Nordisk’s Ozempic Pill Hits Shelves as Q1 Earnings Loom and Valuation Debate Deepens #debate #earnings #hits #Loom #Nordisk’s #novo #NovoNordisk #ozempic #pill #Shelves #Valuation

https://www.europesays.com/dk/73271/ Q1 Earnings Loom as Valuation Debate Intensifies #check #debate #earnings #faces #Intensifies #Loom #Nordisk #novo #NovoNordisk #reality #Valuation

https://www.europesays.com/dk/73025/ FDA Curbs Copycats as Ozempic Pill Replaces Rybelsus #Copycats #Curbs #double #FDA #Nordisk’s #novo #NovoNordisk #ozempic #pill #Replaces #win

https://www.europesays.com/dk/72543/ Generics, Price Wars, and a Steep Valuation Gap #faces #generics #Nordisk #novo #NovoNordisk #Perfect #price #Steep #Storm #Valuation #wars

https://www.europesays.com/dk/72312/ Novo Nordisk’s Hemophilia Data Offers Rare Bright Spot as Revenue Guidance Darkens #Bright #data #guidance #Hemophilia #Nordisk’s #novo #NovoNordisk #Offers #Rare #revenue #Spot

https://www.europesays.com/dk/72215/ Novo Nordisk Caught Between FDA Tailwind and a Brutal Revenue Outlook #Between #Brutal #Caught #FDA #Nordisk #novo #NovoNordisk #outlook #revenue #Tailwind

https://www.europesays.com/dk/71682/ Novo Nordisk’s Hemophilia Breakthrough Fails to Distract From Canadian Generic Blow #Blow #Breakthrough #Canadian #Distract #Fails #from #Generic #Hemophilia #Nordisk’s #novo #NovoNordisk

https://www.europesays.com/dk/71476/ Canadian Generic Launch and Q1 Results Loom #Canadian #faces #Generic #Launch #Loom #Nordisk #novo #NovoNordisk #results #tests #Twin

https://www.europesays.com/dk/70821/ Novo Nordisk’s Teen Trial Victory Can’t Mask the Storm Brewing in Canada #Brewing #Can’t #Canada #Mask #Nordisk’s #novo #NovoNordisk #Storm #teen #Trial #victory